ϩ sparks originating from ryanodine receptors (RyRs) are known to cause membrane hyperpolarization and vasorelaxation in systemic arterial myocytes. By contrast, we have found that Ca 2ϩ sparks of pulmonary arterial smooth muscle cells (PASMCs) are associated with membrane depolarization and activated by endothelin-1 (ET-1), a potent vasoconstrictor that mediates/modulates acute and chronic hypoxic pulmonary vasoconstriction. In this study, we characterized the effects of ET-1 on the physical properties of Ca 2ϩ sparks and probed the signal transduction mechanism for spark activation in rat intralobar PASMCs. Application of ET-1 at 0.1-10 nM caused concentration-dependent increases in frequency, duration, and amplitude of Ca 2ϩ sparks. The ET-1-induced increase in spark frequency was inhibited by BQ-123, an ET A-receptor antagonist; by U-73122, a PLC inhibitor; and by xestospongin C and 2-aminoethyl diphenylborate, antagonists of inositol trisphosphate (IP 3) receptors (IP3Rs 
ϩ sparks originating from ryanodine receptors (RyRs) are known to cause membrane hyperpolarization and vasorelaxation in systemic arterial myocytes. By contrast, we have found that Ca 2ϩ sparks of pulmonary arterial smooth muscle cells (PASMCs) are associated with membrane depolarization and activated by endothelin-1 (ET-1), a potent vasoconstrictor that mediates/modulates acute and chronic hypoxic pulmonary vasoconstriction. In this study, we characterized the effects of ET-1 on the physical properties of Ca 2ϩ sparks and probed the signal transduction mechanism for spark activation in rat intralobar PASMCs. Application of ET-1 at 0.1-10 nM caused concentration-dependent increases in frequency, duration, and amplitude of Ca 2ϩ sparks. The ET-1-induced increase in spark frequency was inhibited by BQ-123, an ET A-receptor antagonist; by U-73122, a PLC inhibitor; and by xestospongin C and 2-aminoethyl diphenylborate, antagonists of inositol trisphosphate (IP 3) receptors (IP3Rs). However, it was unrelated to sarcoplasmic reticulum Ca 2ϩ content, activation of L-type Ca 2ϩ channels, PKC, or cADP ribose. Photorelease of caged-IP3 indicated that Ca 2ϩ release from IP3R could cross-activate RyRs to generate Ca 2ϩ sparks. Immunocytochemistry showed that the distributions of IP 3Rs and RyRs were similar in PASMCs. Moreover, inhibition of Ca 2ϩ sparks with ryanodine caused a significant rightward shift in the ET-1 concentration-tension relationship in pulmonary arteries. These results suggest that ET-1 activation of Ca 2ϩ sparks is mediated via the ETA receptor-PLC-IP 3 pathway and local Ca 2ϩ cross-signaling between IP 3Rs and RyRs; in addition, this novel signaling mechanism contributes significantly to the ET-1-induced vasoconstriction in pulmonary arteries. endothelin; pulmonary arteries; photorelease; pulmonary artery smooth muscle cells; endothelin-1; calcium ion ELEVATION (21, 23, 30) . By contrast, thorough studies in cerebral arteries showed that coordinated local Ca 2ϩ releases from clusters of RyRs, or "Ca 2ϩ sparks", function as the frequency-dependent negative modulators of membrane potential (21, 35, 38) . They cause transient but large increases of [Ca 2ϩ ] i in the subsarcolemmal spaces to activate nearby Ca 2ϩ -activated K ϩ channels and generate spontaneous transient outward currents (STOCs), leading to membrane hyperpolarization, reduction in Ca 2ϩ influx through L-type Ca 2ϩ channels, and vasodilation. It has been suggested that vasoconstrictors, such as norepinephrine, may enhance vasoconstriction by reducing Ca 2ϩ spark frequency (3, 20, 30) to relieve the hyperpolarization imposed by Ca 2ϩ -activated K ϩ (K Ca ) channels; and vasodilators, such as nitric oxide and carbon monoxide, may potentiate vasorelaxation by enhancing spark frequency to activate STOCs (4, 19, 41, 49) . Because of their highly localized and transient nature, Ca 2ϩ sparks are thought to have little contribution to myofilament activation and smooth muscle contraction.
However, the regulation of vascular reactivity varies among different vascular beds because of their specialized physiological functions. The divergence reaches the extreme between systemic and pulmonary arteries. For example, pulmonary arteries have a much lower basal tone compared with systemic arteries and constrict instead of dilate in response to hypoxia. The functions and regulations of Ca 2ϩ sparks in pulmonary and systemic arteries also appear to be different. Developmental studies showed that STOCs, hence Ca 2ϩ sparks, are very active in fetal pulmonary artery smooth muscle cells (PASMCs), and their activity diminishes with maturation (39, 43) . This is in marked contrast to the hundredfold increase in Ca 2ϩ spark and STOC frequencies during maturation in systemic arterial myocytes (14) . We have recently characterized Ca 2ϩ sparks in rat intralobar PASMCs and found that, despite the fact that their spatiotemporal properties are similar to those of systemic myocytes, pulmonary Ca 2ϩ sparks possess unique physiological properties. They are usually associated with membrane depolarization instead of hyperpolarization and are activated specifically by the vasoconstrictor endothelin-1 (ET-1) but not by norepinephrine, even though both elicited similar global Ca 2ϩ transients (42) . These findings raise the intriguing possibility that Ca 2ϩ sparks may increase vasomotor tone and participate specifically in the ET-1-mediated contraction of pulmonary arteries. This notion bears special significance because ET-1 has been implicated as a major modulator or mediator of hypoxia-induced pulmonary hypertension. Antagonists of ET receptors have been shown to prevent and reverse acute and chronic hypoxia-induced pulmonary hypertension in intact animals (6, 10) . Furthermore, a threshold concentration (0.1 nM) of ET-1, which itself did not cause an increase in global Ca 2ϩ concentration ([Ca 2ϩ ]) or contraction, was found to potentiate hypoxia-induced contraction in PASMCs and restore acute hypoxic constriction in endothelium-denuded distal pulmonary arteries (27, 45) . Because of these important physiological implications, we sought to determine in the present study 1) the concentrationdependent effects of ET-1 on the frequency of occurrence and the spatiotemporal properties of Ca 2ϩ sparks, 2) the contribution of Ca 2ϩ sparks in ET-1-induced pulmonary vasoconstriction, and 3) the signal transduction mechanism through which ET-1 regulates Ca 2ϩ sparks.
MATERIALS AND METHODS
Isolation and culture of PASMCs. PASMCs were enzymatically isolated and transiently cultured as previously described (47) . The procedures involving animals have been reviewed and approved by the Johns Hopkins University Animal Care and Use Committee. Briefly, male Wistar rats (150-200 g) were injected with heparin and anesthetized with pentobarbital sodium (130 mg/kg ip). They were exsanguinated, and the lungs were removed and transferred to a petri dish filled with HEPES-buffered salt solution (HBSS) containing (in mM) 130 NaCl, 5 KCl, 1.2 MgCl 2, 1.5 CaCl2, 10 HEPES, and 10 glucose, pH 7.4 (adjusted with NaOH). Second-and third-generation intrapulmonary arteries (ϳ300-800 m) were isolated and cleaned free of connective tissue. The endothelium was removed by gently rubbing the luminal surface with a cotton swab. Arteries were then allowed to recover for 30 min in cold (4°C) HBSS, followed by 20 min in reduced-Ca 2ϩ (20 M) HBSS at room temperature. The tissue was digested at 37°C for 20 min in 20 M Ca 2ϩ HBSS containing collagenase (type I, 1,750 U/ml), papain (9.5 U/ml), BSA (2 mg/ml), and dithiothreitol (1 mM), then removed, and washed with Ca 2ϩ -free HBSS to stop digestion. Single smooth muscle cells were dispersed gently by trituration with a small-bore pipette in Ca 2ϩ -free HBSS at room temperature. The cell suspension was then placed on 25-mm glass coverslips and transiently (16-24 h ) cultured in Ham's F-12 medium (with L-glutamine) supplemented with 0.5% FCS, 100 U/ml streptomycin, and 0.1 mg/ml penicillin.
Measurement of Ca
2ϩ sparks. Ca 2ϩ sparks were visualized as previously described (42) using the membrane-permeable Ca 2ϩ -sensitive fluorescent dye fluo 3-AM. PASMCs were loaded with 5-10 M fluo 3-AM (dissolved in DMSO with 20% pluronic acid) for 30-45 min at room temperature (ϳ22°C) in normal Tyrode solution containing (in mM) 137 NaCl, 5.4 KCl, 2 CaCl 2, 1 MgCl2, 10 HEPES, and 10 glucose, pH 7.4 (adjusted with NaOH). Cells were then washed thoroughly with Tyrode solution to remove extracellular fluo 3-AM and rested for 15-30 min in a cell chamber to allow for complete deesterification of cytosolic dye. Confocal images were acquired using a Zeiss LSM-510 inverted confocal microscope (Carl Zeiss) with a Zeiss Plan-Neofluor ϫ40 oil immersion objective [numerical aperture (NA) ϭ 1.3]. The confocal pinhole was set to render a spatial resolution of 0.4 m in the x-y axis and 1.7 m in the z-axis. Fluo 3-AM was excited by the 488-nm light of an argon laser, and fluorescence was measured at Ͼ505 nm. Images were acquired in the line scan mode (digital zoom rendering a 38-m scan line), scanning at 0.075 m/pixel, 512 pixel/line at 2-ms intervals for 512 lines/image from different cells within the same culture dish before and after drug application. Photobleaching and laser damage to the cells were minimized by attenuating the laser to ϳ1% of its maximum power (25 mW) with an acousto-optical tunable filter. Only 10 images (once every 10 s) were taken from each cell. Cells that did not respond to an external solution containing 10 mM Ca 2ϩ and 0.5 mM caffeine applied at the end of experiments were discarded. All experiments were performed at room temperature.
Photolysis of caged inositol trisphosphate. PASMCs were loaded with 2 M of a caged membrane-permeant derivative of inositol trisphosphate (IP3), ci-IP3/PM (L1-27), that is structurally similar to the original caged derivative of IP3 (cm-IP3) (26) , except that the 2-and 3-hydroxyl groups of the inositol ring are protected as an acetonide (isopropylidene). Like cm-IP3/PM, ci-IP3/PM causes Ca 2ϩ release from IP3R-gated stores upon ultraviolet (UV)-induced photolysis (Li, unpublished observation). It was dissolved in DMSO with 20% pluronic acid, mixed together with the Ca 2ϩ indicator dye fluo 3-AM, and applied to PASMCs on coverslips for 30-45 min. After being washed, cells were incubated for another 20-30 min for deesterification before imaging. The caged IP3 was released by photolysis of the compound using an N2 pulse laser [model GL-3300 (PTI), maximum pulse energy of 2 mJ] at the wavelength of 337 nm. The laser pulse energy was attenuated to ϳ300 J and delivered to PASMCs using UV-enhanced fiber-optics (400 m in diameter) positioned Ͻ50 m from the myocytes. Only one photolysis was induced in each cell.
Isometric contraction. Intralobar pulmonary arteries (300-800 m OD) were isolated and placed in oxygenated modified Krebs solution containing (in mM) 118 NaCl, 4.7 KCl, 0.57 MgSO4, 1.18 KH2PO4, 25 NaHCO3, 10 dextrose, and 2.5 CaCl2. They were cleaned of connective tissue and cut into 4-mm lengths. Endothelium was disrupted by gently rubbing the lumen with a small wooden stick, and the arterial rings were suspended between two stainless steel stirrups in organ chambers filled with modified Krebs solution for isometric tension recording. The solution was gassed with 16% O2-5% CO2 to maintain a pH of 7.4 and the temperature at 37°C. Isometric contraction was measured using a strain gauge connected to a Grass polygraph. The resting tension was adjusted to 1 g. The arteries were exposed to 80 mM KCl to established maximum contraction and to phenylephrine (3 ϫ 10 Ϫ7 M) followed by ACh (10 Ϫ6 M) to verify complete disruption of endothelium.
Immunolocalization of RyRs and IP3Rs. PASMCs were fixed in 2% paraformaldehyde for 10 min. The cells were washed with 0.75% glycine in PBS for 30 min, followed by permeabilization with 0.05% Triton X-100 for 15 min. The cells were then incubated with a combination of unconjugated donkey anti-rabbit IgG, anti-mouse IgG, or anti-mouse IgM antibodies (1:20) to block nonspecific binding for 2 h and then incubated overnight with a combination of isoformspecific anti-RyR and anti-IP 3R primary antibodies. Primary antibodies included rabbit polyclonal anti-IP3R type I, type II, and type III (1:100; Affinity Bioreagents); mouse monoclonal IgG anti-IP 3R (1:100; Chemicon) and mouse monoclonal IgG anti-IP3R type III (1:50, Transduction Laboratory); mouse monoclonal IgG anti-RyR type II (1:100; Affinity Bioreagents); and mouse monoclonal IgM anti-RyR type I (1:100; Upstate). Antibody-specific binding was visualized with either donkey CY2-conjugated or CY5-conjugated secondary antibodies (1:100; Jackson Immunoresearch Laboratory), which were affinity purified for multiple labeling. BSA (0.2%) and Triton X-100 (0.05%) were included in PBS for antibody dilution. Incubation was carried out in a moistened chamber at 4°C. Immunolocalization was examined with an MRC-1000 confocal scanning unit (Bio-Rad) equipped with a krypton-argon laser, and images were acquired with a Zeiss plan-apochromat objective (ϫ63, NA ϭ 1.4). PASMCs without exposure to primary antibodies were used as a negative control.
Data analysis. Ca 2ϩ spark detection was guided by an algorithm custom written using the Interactive Data Language software (Research Systems, Boulder, CO). The program identified Ca 2ϩ sparks on the basis of their statistical deviation from background noise, similar to that described previously by Cheng et al. (8) . Fluorescence signals (F) of each confocal image were first normalized in terms of F/F 0, where F0 is the baseline fluorescence in a region of the image without Ca 2ϩ sparks. The mean and variance ( 2 ) of the normalized image were determined. Ca 2ϩ sparks were then identified based on local fluorescence intensity greater than mean ϩ 3 ͌ 2 . Amplitudes of the Ca 2ϩ sparks were then calibrated to absolute [Ca 2ϩ ] by a pseudoratio method (7) using the equation [Ca 2ϩ ]rest), in the absence of ET-1, was assumed to be 100 nM, and the values in the presence of different concentrations of ET-1 were determined from separate groups of cells independently. The duration and spread (or width) of Ca 2ϩ sparks were quantified as the full-duration half-maximum (FDHM) and full-width halfmaximum (FWHM), respectively. The spark frequency of each cell was defined as the number of sparks detected per second in a scan line of 38 m. In some images, large increases in global [Ca 2ϩ ] or clustering of sparks rendered individual sparks indiscernible. These global [Ca 2ϩ ] increases were not analyzed with the program. Throughout the paper, data are expressed as means Ϯ SE. The number of cells is specified in the text. Statistical significance ( P Ͻ 0.05) of the changes in spark characteristics was assessed by paired or unpaired Student's t-tests, one-way ANOVA with Newman-Keul's post hoc analyses, or nonparametric MannWhitney U-tests, wherever applicable.
RESULTS

Characterization of ET-1-induced Ca
2ϩ spark. Under steady-state conditions, ET-1 at a concentration between 0.1 and 10 nM elicited concentration-dependent increases in spark frequency from the control of 0.62 Ϯ 0.08 s Ϫ1 (n ϭ 61 cells) to a maximum of 2.24 Ϯ 0.20 s
Ϫ1
(n ϭ 46 cells, P Ͻ 0.001) at 10 nM ET-1 in rat intralobar PASMCs (Fig. 1, A and B) . The effect was apparent even at 0.1 nM as a twofold increase in spark frequency (1.34 Ϯ 0.15 s Ϫ1 , P Ͻ 0.001, n ϭ 62 cells). Spark amplitude, expressed as ⌬[Ca 2ϩ ] i , was significantly increased at all concentrations of ET-1 tested (control: 43.7 Ϯ 1.5; 10 nM ET-1: 71.4 Ϯ 1 nM, P Ͻ 0.001). Spark duration (FDHM) was also significantly prolonged at ET concentrations Ն1 nM (control: 35.6 Ϯ 1.6 ms; 10 nM ET-1: 66.4 Ϯ 1.7 ms, P Ͻ 0.001). By contrast, the spatial spread (FWHM) was increased only slightly at the highest concentration (10 nM) of ET-1.
Since the distributions of spark amplitude, duration, and size are non-Gaussian because of the inherited property of off-center sampling in line scan confocal imaging (8, 40) , nonparametric statistics were applied to further compare spark properties in the absence and presence of 3 nM ET-1 (Fig. 2) . When compared with the Mann-Whitney U-test, the amplitude of Ca 2ϩ sparks elicited by ET-1 was found to be significantly higher than that of control (control: median ϭ 35.6 nM, 90% range ϭ 20.3-94.4 nM; ET-1: median ϭ 64.0 nM, 90% range ϭ 35.8-140.7 nM; P Ͻ 0.001). Spark duration (FDHM) was significantly longer (control: median ϭ 26 ms, 90% range ϭ 14-80 ms; ET-1: median ϭ 36 ms, 90% range ϭ 16-108 ms; P Ͻ 0.001), whereas the spread (FWHM) was unaltered (control: median ϭ 1.57 m, 90% range ϭ 0.9-2.88 m; ET-1: median ϭ 1.50 m, 90% range ϭ 0.6-3.2 m) in the presence of ET-1. Therefore, both parametric and nonparametric analyses indicate that ET-1 caused dramatic increases in Ca 2ϩ spark frequency, duration, and amplitude in rat PASMCs. Ca 2ϩ sparks activated by ET-1 originated primarily from Ca 2ϩ release via RyRs. Pretreatment of PASMCs with 50 M ryanodine for 30 min almost completely abolished spontaneous Ca 2ϩ sparks generated at rest, and in the presence of ET-1 (Fig. 3 A) . Residual Ca 2ϩ sparks were most likely the result of incomplete block of RyRs, instead of originating from another source, because the amplitude, duration, and size of these sparks were similar to those recorded in the absence of ryanodine.
Ca 2ϩ sparks and ET-1-induced contraction. The contribution of Ca 2ϩ sparks to ET-1-induced vasoconstriction was evaluated in endothelium-denuded intralobar pulmonary arterial rings. ET-1 elicited a sustained increase in tension, beginning at 0.1 nM, and reached the maximum at 10 nM, with an EC 50 of 0.88 Ϯ 0.13 nM ( n ϭ 9; Fig. 3 B) . Maximum tension elicited by ET-1 was about two times that elicited by 80 mM KCl (KCl: 0.33 Ϯ 0.03 g; ET-1: 0.59 Ϯ 0.05 g). Pretreatment with 50 M ryanodine for 30 min increased the threshold concentration for contraction and shifted the concentration-response curve of ET-1 to the right (EC 50 ϭ 2.43 Ϯ 0.19 nM, n ϭ 10, P Ͻ 0.001) but had no apparent effect on the baseline or maximal tension.
Probing the mechanisms: L-type Ca 2ϩ channels, sarcoplasmic reticulum Ca 2ϩ , and cADP-ribose. To explore the mechanism through which ET-1 enhances Ca spark frequency, the common pathways for spark activation were examined. Inhibition of L-type Ca 2ϩ channels with 10 M nifedipine had no significant effect on spontaneous Ca 2ϩ sparks in PASMCs at rest, or in the presence of 3 nM ET-1. Similarly, pretreatment of PASMCs with a membrane-permeant cADP-ribose (cADPR) antagonist, 8-bromo-cADPR (100 M), for 20 min had no significant effect on resting spark frequency and failed to reduce spark frequency in the presence of ET-1.
Because an increase in sarcoplasmic reticulum (SR) luminal Ca 2ϩ is known to enhance spark frequency, SR Ca 2ϩ content was estimated by the exhaustive release of SR Ca 2ϩ induced by a high concentration of caffeine. Rapid application of 10 mM caffeine for 10 s to PASMCs activated a large Ca 2ϩ transient with a magnitude proportional to the amount of SR Ca 2ϩ (Fig. 4B) . The measurement was highly repeatable, as a Ca , n ϭ 50 cells) but completely abolished Ca 2ϩ sparks activated by ET-1 (3 nM; 0.76 Ϯ 0.11 s Ϫ1 , n ϭ 52 cells; Fig. 5A ). In contrast, the ET B receptor antagonist BQ-788 (1 M) failed to inhibit the ET-1-induced Ca 2ϩ sparks. U-73122 (100 nM), a specific PLC inhibitor, had no effect on the resting spark frequency but almost completely inhibited the ET-1-induced increase in spark frequency (1.11 Ϯ 0.17 s Ϫ1 , n ϭ 50 cells; Fig. 5B ). Moreover, caffeine at 0.5 mM caused a significant increase in spark frequency (1.66 Ϯ 0.28 s Ϫ1 , n ϭ 16 cells) in the presence of U-73122, suggesting that the antagonist did not disrupt the ability of RyRs to generate Ca 2ϩ sparks. Hence the increase in spark frequency was mediated exclusively through ET A receptor-dependent activation of PLC. Activation of PLC increases the production of IP 3 and diacylglycerol (DAG), the latter of which is the endogenous activator of PKC. To examine the PLC signaling cascade in the modulation of Ca 2ϩ sparks, PASMCs were exposed to staurosporine (2 nM), a PKC inhibitor. Staurosporine had no effect on resting spark frequency and failed to prevent the ET-1 effect on Ca 2ϩ sparks (Fig. 5C) . Moreover, 1-oleoyl-2-acetyl-sn-glycerol (OAG, 100 M), an analog of DAG, also failed to mimic the effect of ET-1. This excluded the involvement of DAG and PKC in the activation of Ca Medians of the frequency distributions were compared, and P values were determined by the Mann-Whitney U-test. NS, not significant. 3 ] increase is illustrated by a surface-plot of Ca 2ϩ fluorescence recorded during a 1.5-s period immediately after photorelease of IP 3 (Fig. 6C) (Fig. 4D) 3 Rs and RyRs in PASMCs were examined further by immunohistocytochemistry. With the use of specific antibodies, two subtypes of RyR (RyR1 and RyR2) and three different subtypes of IP 3 R (IP 3 R1, IP 3 R2, and IP 3 R3) were detected in PASMCs. RyR1 and RyR2 were found in both sarcolemma and cytoplasm, and their distributions were very similar, as shown by the high degree of overlapping of their immunofluorescent signals (Fig. 7) . Similar spatial distributions were also observed when RyR1 or RyR2 was doubled stained with another antibody raised against a common domain of IP 3 R1, IP 3 R2, and IP 3 R3. When antibodies specific to individual IP 3 R subtypes were used, IP 3 R3 exhibited a similar, whereas IP 3 R1 or IP 3 R2 showed a less consistent, pattern of localization as RyRs. These results provide morphological evidence in support of the notion that some IP 3 Rs and RyRs are closely associated in PASMCs.
Photorelease of IP
DISCUSSIONS
ET-1, the most potent endothelial-derived vasoconstrictor, is known to exert its action through activation of ET A and ET B receptors, both of which are present abundantly in pulmonary arterial smooth muscle (25, 29) . Binding of ET to its receptors triggers a wide spectrum of responses, including membrane depolarization, inhibition of voltage-gated K ϩ channels, activation of L-type Ca 2ϩ current and nonselective cation channels, mobilization of intracellular Ca 2ϩ , and an increase in myofilament sensitivity (11, 13, 16, 18, 33 , ]i induced by 10 mM caffeine before and after 10 min exposure to ET-1 (3 nM, n ϭ 7 cells). * Significant difference from the value obtained before ET-1 exposure. 36, 46, 47) . Depending on the type of vascular tissue, all or several of these mechanisms operate synergistically to cause vasoconstriction. In the present study, we have provided direct evidence suggesting that Ca 2ϩ spark activation serves as a novel mechanism of ET-1-dependent vasoconstriction in pulmonary arteries.
ET-1 at 0.1-10 nM caused a concentration-dependent increase in the frequency, duration, and amplitude of Ca 2ϩ sparks in PASMCs. The most dramatic effect was the increase in the apparent spark frequency, which was significant at the lowest concentration and reached fourfold at 10 nM ET-1. In fact, the actual spark frequency at higher ET-1 concentrations could be even higher because of the periodic occurrence of global increases in [Ca 2ϩ ] and Ca 2ϩ waves, which rendered Ca 2ϩ sparks indiscernible. Ca 2ϩ sparks activated by ET-1 originated exclusively from RyRs, as they were abolished by ryanodine, and contributed significantly to ET-1-induced pulmonary vasoconstriction. The rightward shift of the ET-1 concentrationtension relationship without a reduction in the maximum developed tension in the presence of ryanodine (Fig. 3B) suggests that Ca 2ϩ sparks contribute to pulmonary vasoconstriction elicited by ET-1, with the highest efficiency at the low concentrations. Our previous study showed that Ca 2ϩ sparks caused membrane depolarization in PASMCs (42) . Such membrane depolarization induced by Ca 2ϩ sparks may potentiate the effect of ET-1 on L-type Ca 2ϩ channel activation (16, 17) by setting membrane potential close to their activation threshold and/or sustaining the elevation of cytoplasmic [Ca 2ϩ ] by reducing Ca 2ϩ removal through the Na ϩ /Ca 2ϩ exchanger. This modulatory mechanism is likely more effective at the lower than higher ET-1 concentrations because all vasoconstrictory mechanisms activated by ET-1 are operated optimally at the higher concentration. It is intriguing that ET-1 activated substantial Ca 2ϩ sparks at 0.1 nM, a threshold concentration that hardly activated any change in global [Ca 2ϩ ] and contraction. This is coincident with the fact that ET-1 at such concentration enhances contraction induced by other agonists through a process called "threshold potentiation" (34, 50) and potentiates dramatically the otherwise insignificant acute hypoxic pulmonary vasoconstriction in PASMCs and endothelium-denuded pulmonary microvessels (27, 45) through a process known as "priming." In these cases, Ca 2ϩ sparks activated by ET-1 at the threshold concentration might have escaped detection by global [Ca 2ϩ ] i measurement and exerted their priming effect through modulation of membrane potential. This interesting possibility needs further future investigations.
In addition to local Ca 2ϩ signaling, Ca 2ϩ sparks of PASMCs may also participate in vasoconstriction by providing Ca 2ϩ for Ca 2ϩ /calmodulin activation of myofilaments. It is apparent in the caged IP 3 experiments that PASMCs are capable of generating a large amount of Ca 2ϩ sparks sufficient to elevate global [Ca 2ϩ ]. It is also consistent with previous whole cell Ca 2ϩ measurements showing that a major component of Ca 2ϩ release induced by ET-1 could be blocked by ryanodine (47) . In this case, ET-1-induced Ca 2ϩ sparks of PASMCs are similar to the evoked Ca 2ϩ sparks of striated muscles (5, 7, 28) , underlying at least in part the global Ca 2ϩ transients for PASMC contraction.
The notion that Ca 2ϩ sparks potentiate the contraction of pulmonary arteries is in contrast to the welldocumented vasodilatory effect in systemic arteries. In systemic vessels, inhibition of Ca 2ϩ sparks with ryanodine causes vasoconstriction (21, 35, 38) . Vasoconstrictors, such as norepinephrine and UTP, were found to cause a reduction in Ca 2ϩ sparks (3, 20, 30 rine and ANG II at low concentration activated Ca 2ϩ sparks but at high concentration elicited Ca 2ϩ waves (1, 2) . Hence, PASMCs are more similar to portal vein myocytes in the regulation of Ca 2ϩ sparks by vasoconstrictors, despite the differences that Ca 2ϩ sparks are usually associated with STOCs in portal vein myoctyes (32) and norepinephrine does not induce Ca 2ϩ sparks in PASMCs (42) .
Our results clearly suggest that activation of Ca 2ϩ sparks by ET-1 is mediated via ET A receptor-dependent activation of PLC. Activation of PLC generates IP 3 and DAG, the latter of which activates multiple effectors through PKC-dependent phosphorylation, including RyRs and L-type Ca 2ϩ channels (24, 31, 48) . However, PKC-dependent phosphorylation is not a major pathway for Ca 2ϩ spark activation, because staurosporine did not antagonize, and OAG did not mimic, the ET-1-induced activation of Ca 2ϩ sparks. Moreover, inhibition of L-type Ca 2ϩ channels with nifedipine was ineffective in ablating Ca 2ϩ sparks elicited by ET-1. This is somewhat surprising because ET-1 has been shown to increase L-type Ca 2ϩ current in systemic myocytes (16, 17) , and activation of L-type Ca 2ϩ channels is known to increase spark frequency in systemic and pulmonary myocytes (22, 35, 42) . In addition, Ca 2ϩ spark activation by ANG II in portal vein myocytes is mediated via L-type Ca 2ϩ channels (1). The paradoxical lack of involvement of L-type Ca 2ϩ channels in spark activation in PASMCs could be explained by the notions that L-type Ca 2ϩ channels are loosely coupled or uncoupled to RyRs, a situation described in nonvascular myocytes (9) , and that the activation of RyRs by ET-1 is dominated by another more efficacious mechanism. This mechanism, however, is neither related to an increase in SR Ca 2ϩ content, because the caffeineinduced Ca 2ϩ transient was in fact reduced in the presence of ET-1, nor related to cADPR production because 8-bromo-cADPR did not block the ET-1-induced change in spark frequency.
On the other hand, our results point unequivocally to the involvement of IP 3 -induced Ca 2ϩ release. Two structurally distinctive antagonists of IP 3 R, 2-APB and xestospongin C, both inhibited almost completely the ET-1-induced Ca 2ϩ sparks. The inhibition was not the result of nonspecific effects of the antagonists because the basal spark frequency and caffeine-induced Ca 2ϩ sparks were unaltered. More convincingly, photorelease of IP 3 directly triggered numerous Ca 2ϩ sparks and large global Ca 2ϩ transients, both of which were completely blocked by 2-APB. These results suggest that IP 3 generation alone is sufficient to account for the activation of Ca 2ϩ sparks, independent of other ET-1-related mechanisms. The absence of "Ca 2ϩ puffs" induced by IP 3 3 Rs exhibit similar distribution patterns in PASMCs (Fig. 4) . Local interactions of the release channels have recently been proposed in portal vein myocytes (2, 15) . In these myocytes, IP 3 Rs and RyRs were found to share a common Ca 2ϩ pool (37) , and spontaneous Ca 2ϩ sparks of large and small sizes generated at a single frequent discharge site (15) . It has been postulated that IP 3 produced by the basal activity of PLC activates IP 3 Rs to recruit neighboring clusters of RyRs within the frequent discharge site to generate large Ca 2ϩ sparks (15) . During agonist stimulation, enhanced production of IP 3 causes large-scale crossactivation of IP 3 Rs and RyRs to generate Ca 2ϩ waves (2) . In contrast, IP 3 Rs and RyRs have been shown to regulate separate Ca 2ϩ pools in canine PASMCs (23) . Ca 2ϩ sparks of rat and canine PASMCs have a size similar to the small regular Ca 2ϩ sparks observed in portal veins, and their occurrence is random with no clear indication of a frequent discharge site (23, 42) . Additionally, inhibition of IP 3 Rs with 2-APB or xestospongin C had no effect on the resting frequency, size, and amplitude of spontaneous Ca 2ϩ sparks (Fig. 5D ), suggesting that IP 3 Rs do not contribute to the basal generation of Ca 2ϩ sparks in rat PASMCs. Nevertheless, despite the differences from portal vein myocytes, our results clearly suggest that cross-activation of RyRs by Ca 2ϩ released from IP 3 Rs did occur in PASMCs. It is apparent both when endogenous generation of IP 3 was activated by ET-1 and when exogenous IP 3 was introduced by flash photolysis. In view of the similar immunostaining patterns of RyRs and IP 3 Rs, it is possible that some RyRs may reside close enough to be activated by the Ca 2ϩ microdomains of IP 3 Rs. Such functional coupling between IP 3 Rs and RyRs may provide a highly efficient amplification mechanism for pharmacomechanical coupling in pulmonary arteries to mobilize Ca 2ϩ simultaneously from IP 3 R-and RyRgated stores upon agonist stimulation.
In conclusion, our present study provides definitive evidence that ET-1 enhances Ca 2ϩ spark generation from RyRs in PASMCs. The process is mediated through the ET A receptor-PLC-IP 3 pathway but is unrelated to SR Ca 2ϩ loading, Ca 2ϩ influx via L-type Ca 2ϩ channels, generation of cADPR, and activation of PKC. Moreover, IP 3 Rs and RyRs are coupled functionally and associated spatially in PASMCs. This local Ca 2ϩ signaling process between IP 3 Rs and RyRs constitutes a novel mechanism that contributes significantly to ET-1-induced pulmonary vasoconstriction.
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